Lai Kuo-Pao, Lai Jiann-Jyh, Chang Philip, Altuwaijri Saleh, Hsu Jong-Wei, Chuang Kuang-Hsiang, Shyr Chih-Rong, Yeh Shuyuan, Chang Chawnshang
George H Whipple Laboratory for Cancer Research, University of Rochester Medical Center, Rochester, New York 14642, USA.
Mol Endocrinol. 2013 Jan;27(1):25-37. doi: 10.1210/me.2012-1244. Epub 2012 Dec 18.
Although thymic involution has been linked to the increased testosterone in males after puberty, its detailed mechanism and clinical application related to T-cell reconstitution in bone marrow transplantation (BMT) remain unclear. By performing studies with reciprocal BMT and cell-specific androgen receptor (AR) knockout mice, we found that AR in thymic epithelial cells, but not thymocytes or fibroblasts, played a more critical role to determine thymic cellularity. Further dissecting the mechanism using cell-specific thymic epithelial cell-AR knockout mice bearing T-cell receptor transgene revealed that elevating thymocyte survival was due to the enhancement of positive selection resulting in increased positively selected T-cells in both male and female mice. Targeting AR, instead of androgens, either via genetic knockout of thymic epithelial AR or using an AR-degradation enhancer (ASC-J9®), led to increased BMT grafting efficacy, which may provide a new therapeutic approach to boost T-cell reconstitution in the future.
尽管胸腺退化与青春期后男性体内睾酮水平升高有关,但其与骨髓移植(BMT)中T细胞重建相关的详细机制和临床应用仍不清楚。通过对相互BMT和细胞特异性雄激素受体(AR)敲除小鼠进行研究,我们发现胸腺上皮细胞中的AR,而非胸腺细胞或成纤维细胞,在决定胸腺细胞数量方面发挥了更关键的作用。使用携带T细胞受体转基因的细胞特异性胸腺上皮细胞AR敲除小鼠进一步剖析机制,发现胸腺细胞存活率提高是由于阳性选择增强,导致雄性和雌性小鼠中阳性选择的T细胞增加。通过胸腺上皮AR基因敲除或使用AR降解增强剂(ASC-J9®)靶向AR而非雄激素,可提高BMT移植效果,这可能为未来促进T细胞重建提供一种新的治疗方法。